期刊文献+

东盟国家幽门螺杆菌感染的处理:曼谷共识报告 被引量:2

Helicobacter pylori management in ASEAN: the Bangkok Consensus Report
下载PDF
导出
摘要 幽门螺杆菌(Helicobacter pylori,H. pylori)感染仍然是慢性胃炎、消化性溃疡、胃腺癌、胃黏膜相关淋巴组织淋巴瘤等重要上消化道疾病的主要原因。东盟国家H. pylori感染的处理:曼谷共识会议聚集了该地区的主要专家队伍,以在临床方面审查和评估H.pylori感染,并制定共识陈述、依据及东盟国家H. pylori感染临床处理的推荐等级。东盟共识会议有34个国际专家参加,他们来自10个东盟成员国及日本、中国台湾和美国。会议主要讨论四个议题:(Ⅰ)流行病学和疾病联系;(Ⅱ)诊断方法;(Ⅲ)处理意见;(Ⅳ)根除后的随访。每个工作组的最终结果将交由所有参会专家投票,由此产生共识。陈述、依据及推荐都从现有证据中形成,以帮助临床医师诊断和治疗H. pylori感染及相关疾病。 Helicobacter pylori ( H.pylori ) infection remains to be the major cause of important upper gastrointestinal diseases such as chronic gastritis, peptic ulcer, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. H.pylori management in ASEAN: the Bangkok Consensus Report gathered key opinion leaders for the region to review and evaluate clinical aspects of H.pylori infection and to develop consensus statements, rationales, and grades of recommendation for the management of H.pylori infection in clinical practice in ASEAN countries. This ASEAN Consensus consisted of 34 international experts from 10 ASEAN countries, Japan, Taiwan, and the United States. The meeting mainly focused on four issues:(Ⅰ) epidemiology and disease association;(Ⅱ) diagnostic tests;(Ⅲ) management;and (Ⅳ) follow-up after eradication. The final results of each workshop were presented for consensus voting by all participants. Statements, rationale, and recommendations were developed from the available current evidence to help clinicians in the diagnosis and treatment of H.pylori and its clinical diseases.
作者 冉丹 吴寒 张振玉 RAN Dan;WU Han;ZHANG Zhenyu(Department of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210000, China)
出处 《胃肠病学和肝病学杂志》 CAS 2019年第5期481-488,共8页 Chinese Journal of Gastroenterology and Hepatology
关键词 东盟国家 共识 幽门螺杆菌 ASEAN countries Consensus Helicobacter pylori
  • 相关文献

参考文献2

二级参考文献24

  • 1Floriana Giorgio,Mariabeatrice Principi,Vincenzo De Francesco,Angelo Zullo,Giuseppe Losurdo,Alfredo Di Leo,Enzo Ierardi.Primary clarithromycin resistance to Helicobacter pylori : Is this the main reason for triple therapy failure?[J].World Journal of Gastrointestinal Pathophysiology,2013,4(3):43-46. 被引量:10
  • 2Vincenzo De Francesco,Enzo Ierardi,Cesare Hassan,Angelo Zullo.Helicobacter pylori therapy:Present and future[J].World Journal of Gastrointestinal Pharmacology and Therapeutics,2012,3(4):68-73. 被引量:7
  • 3Javier Molina–Infante,Marco Romano,Miguel Fernandez–Bermejo,Alessandro Federico,Antonietta G. Gravina,Liliana Pozzati,Elena Garcia–Abadia,Gema Vinagre–Rodriguez,Carmen Martinez–Alcala,Moises Hernandez–Alonso,Agnese Miranda,Maria Rosaria Iovene,Carmen Pazos–Pacheco,Javier P. Gisbert.Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance[J].Gastroenterology.2013(1)
  • 4Luigi Gatta,Nimish Vakil,Dino Vaira,Carmelo Scarpignato.Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy[J].BMJ (aug ).2013(aug071)
  • 5Sotirios D. Georgopoulos,Elias Xirouchakis,Beatriz Martinez‐Gonzalez,Dionyssios N. Sgouras,Charikleia Spiliadi,Andreas F. Mentis,Fotini Laoudi.Clinical Evaluation of a Ten‐Day Regimen with E someprazole, M etronidazole, A moxicillin, and C larithromycin for the Eradication of H elicobacter pylori in a High Clarithromycin Resistance Area[J].Helicobacter.2013(6)
  • 6Ahmad Shavakhi,Elham Tabesh,Arezoo Yaghoutkar,Houriye Hashemi,Faezeh Tabesh,Mahsa Khodadoostan,Mohammad Minakari,Sara Shavakhi,Ali Gholamrezaei.The Effects of Multistrain Probiotic Compound on Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Infection: A Randomized Placebo‐Controlled Triple‐Blind Study[J].Helicobacter.2013(4)
  • 7Xiao Liang,Xiaoqing Xu,Qing Zheng,Wei Zhang,Qinjuan Sun,Wenzhong Liu,Shudong Xiao,Hong Lu.Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study[J].Clinical Gastroenterology and Hepatology.2013(7)
  • 8Ibrahim Koral Onal,Hale Gokcan,Emine Benzer,Gulay Bilir,Erkin Oztas.What is the impact of Helicobacter pylori density on the success of eradication therapy: A clinico-histopathological study[J].Clinics and Research in Hepatology and Gastroenterology.2013
  • 9Sotirios D Georgopoulos,Vasilios Papastergiou,Stylianos Karatapanis.Current options for the treatment of Helicobacter pylori[J].Expert Opinion on Pharmacotherapy.2013(2)
  • 10Javier P. Gisbert,Javier Molina-Infante,Alicia C. Marin,Gemma Vinagre,Jesus Barrio,Adrian Gerald McNicholl.Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple “sequential” or “concomitant” treatment to eradicate H. pylori infection[J].Scandinavian Journal of Gastroenterology.2013(6)

共引文献15

同被引文献40

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部